Tergus Grows Manufacturing Capabilities
The Company Has Added State-of-the-Art Equipment That Will Further Enhance Manufacturing Functionality and Capability
(firmenpresse) - RESEARCH TRIANGLE PARK, NC -- (Marketwired) -- 09/17/14 -- Tergus () has acquired cutting-edge equipment that will aid in manufacturing topical pharmaceutical supplies for clinical trials. The company, currently working from a state-of-the-art facility at Research Triangle Park in Durham, North Carolina, delivers topical pharmaceutical formulation, analytical R&D, IVRT testing and manufacturing. Tergus has a stellar, 18-year track record of successfully providing comprehensive services as well as regulatory guidance, documentation and support.
"We are excited to be furthering the functionality of our manufacturing operation," said Vijendra Nalamothu, PhD, CEO and co-founder of Tergus. "Our clients are our objective; this new equipment will ensure that our clients are getting the best we can provide through the entire process of research, development, analysis, testing and manufacturing."
There are three pieces of new machinery: an AXOMIX turboemulsifier, a microfluidizer processor and an IMPAK tube sealer. This top-of-the-line equipment will enhance the company's manufacturing as well as deliver the most positive outcomes. From mixing stable creams and balms to achieving uniform particle size reduction to regulating air pressure, these machines will guarantee accuracy and efficacy in producing supplies for clinical trials.
Tergus offers topical pharmaceutical formulation, analytics, In Vitro Release Testing (IVRT), skin biology and clinical supplies manufacturing GMP laboratories. The company also has several banks of IVRT and skin penetration cells and advanced clean-room environments.
"We founded Tergus intending to become the market leader in start-to-finish topical product strategy and development," Kailas Thakker, PhD, Tergus president and co-founder said. "These new technologies and our active engagement in utilizing them for the highest end results will allow us to meet our goals."
Tergus Pharma's services range from formulation through testing and manufacturing. The company leads the pack in topical pharmaceutical services.
Tergus () is the market leader in full-service topical pharmaceutical research, development, testing and manufacturing. The company has been an industry leader in topical pharmaceuticals for 18 years and has a state-of-the-art laboratory facility at Research Triangle Park in Durham, North Carolina. The company has a long and stellar reputation for delivering quality and results for clients from formulation through manufacturing. The company's motto is "Think Topical. Think Tergus."
Leslie Proctor
Springboard5
(801) 208-1100
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 17.09.2014 - 11:00 Uhr
Sprache: Deutsch
News-ID 336547
Anzahl Zeichen: 2774
contact information:
Town:
RESEARCH TRIANGLE PARK, NC
Kategorie:
Drugs
Diese Pressemitteilung wurde bisher 199 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Tergus Grows Manufacturing Capabilities"
steht unter der journalistisch-redaktionellen Verantwortung von
Tergus (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
